IL6 and hepatocellular carcinoma: A previous study demonstrated that IL-6 generated by TAMs induces upregulation of CD47 on hepatoma cells via the STAT3 signaling pathway, subsequently influencing TAM-mediated phagocytosis, promoting tumor progression in HCC, and leading to poor prognosis (42).